Radiation
High dose rate prostate brachytherapy
High dose rate prostate brachytherapy is a radiation therapy with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
RADIATION
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution2 total trials
Phase 3Large-scale testing
1(50.0%)
N/ANon-phased studies
1(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Active, not recruiting2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
Phase 3
Trials by Phase
Phase 31 (50.0%)
N/A1 (50.0%)
Trials by Status
active_not_recruiting267%
recruiting133%
Recent Activity
3 active trials
Showing 3 of 3
recruiting
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
NCT06200974
active_not_recruitingnot_applicable
LDR vs. HDR Brachytherapy for Prostate Cancer
NCT03426748
active_not_recruitingphase_3
Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer
NCT02692105
Clinical Trials (3)
Showing 3 of 3 trials
NCT06200974
Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
NCT03426748Not Applicable
LDR vs. HDR Brachytherapy for Prostate Cancer
NCT02692105Phase 3
Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- RADIATION
- Total Trials
- 3